ESSA.JK's stock price, like other stocks, is influenced by various factors. Company Performance: Strong financial results, positive clinical trial outcomes, and successful product launches typically drive the price up. Conversely, poor performance, failed trials, or regulatory setbacks can cause it to fall. Industry Trends: Developments in the pharmaceutical industry, especially advancements in oncology and prostate cancer treatments, can affect investor sentiment and the overall valuation of ESSA.JK. Market Conditions: General economic conditions, investor confidence, and broader market trends influence stock prices. A bull market often lifts most stocks, while a bear market can depress them. Regulatory Environment: Changes in regulations related to drug development, approval processes, or pricing can significantly impact ESSA.JK's future prospects and stock price. Competition: The emergence of competing therapies or companies in the prostate cancer space can put pressure on ESSA.JK's potential market share and revenue, affecting its stock valuation.